Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zimmer mobile bearing knee

This article was originally published in The Gray Sheet

Executive Summary

Orthopedic implant maker gains PMA approval for its NexGen LPS-Flex mobile bearing knee Dec. 10, setting the stage for a limited market release in January. The device should be available throughout the United States by mid-2008, according to the company. Johnson & Johnson/DePuy is the only other firm to have received PMA approval for mobile bearing knees. In contrast to traditional artificial knees, the polyethylene articulating surface of mobile bearing knees is "free to rotate slightly along with the patient's natural movement," Zimmer explains. LPS-Flex facilitates minimally invasive placement and "when used with the LPS-Flex femoral component ... is designed to safely accommodate active deep flexion of up to 155 degrees." FDA notes that Zimmer will conduct a 10-year postapproval study to evaluate long-term safety and effectiveness

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025607

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel